Viewing Study NCT00602433


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2025-12-30 @ 6:02 PM
Study NCT ID: NCT00602433
Status: COMPLETED
Last Update Posted: 2011-04-15
First Post: 2008-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
Sponsor: Northwestern University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Nonsmall Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced nonsmall cell lung cancer View